Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice
Soluble epoxide hydrolase (sEH), a key enzyme in the metabolism of vasodilatory epoxyeicosatrienoic acids (EETs), is sexually dimorphic, suppressed by estrogen, and contributes to underlying sex differences in cerebral blood flow and injury after cerebral ischemia. We tested the hypothesis that sE...
Main Authors: | Kristen L Zuloaga, Wenri eZhang, Natalie E Roese, Nabil eAlkayed |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00290/full |
Similar Items
-
The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
by: Olivier Varennes, et al.
Published: (2020-06-01) -
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019-01-01) -
Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
by: Hsueh-Te Lee, et al.
Published: (2019-12-01) -
The characterization and purification of rabbit liver microsomal epoxide hydrolases
by: Timms, C. W.
Published: (1987)